Anne E. Hammer

3.1k total citations
59 papers, 2.1k citations indexed

About

Anne E. Hammer is a scholar working on Pediatrics, Perinatology and Child Health, Psychiatry and Mental health and Rheumatology. According to data from OpenAlex, Anne E. Hammer has authored 59 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Pediatrics, Perinatology and Child Health, 37 papers in Psychiatry and Mental health and 19 papers in Rheumatology. Recurrent topics in Anne E. Hammer's work include Epilepsy research and treatment (37 papers), Pharmacological Effects and Toxicity Studies (37 papers) and Systemic Lupus Erythematosus Research (18 papers). Anne E. Hammer is often cited by papers focused on Epilepsy research and treatment (37 papers), Pharmacological Effects and Toxicity Studies (37 papers) and Systemic Lupus Erythematosus Research (18 papers). Anne E. Hammer collaborates with scholars based in United States, United Kingdom and Italy. Anne E. Hammer's co-authors include Alain Vuong, Pamela S. Barrett, John A. Messenheimer, Robert P. Kustra, Victor Biton, A. Vuong, David A. Roth, J. Chris Sackellares, James Groark and Toufic Fakhoury and has published in prestigious journals such as Neurology, PEDIATRICS and Annals of the Rheumatic Diseases.

In The Last Decade

Anne E. Hammer

59 papers receiving 2.0k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Anne E. Hammer 1.2k 1.1k 477 337 258 59 2.1k
G D Perkin 354 0.3× 210 0.2× 142 0.3× 173 0.5× 208 0.8× 63 2.5k
Ramesh K. Gupta 185 0.2× 124 0.1× 320 0.7× 197 0.6× 173 0.7× 74 1.4k
Mustafa Uzan 403 0.3× 290 0.3× 60 0.1× 41 0.1× 136 0.5× 105 1.7k
Peter R. Kinkel 520 0.4× 109 0.1× 217 0.5× 56 0.2× 164 0.6× 31 1.7k
Andrew Lux 1.5k 1.3× 1.1k 1.0× 41 0.1× 16 0.0× 69 0.3× 43 2.5k
Roberto Ratiglia 57 0.0× 365 0.3× 136 0.3× 139 0.4× 770 3.0× 102 3.6k
Mustafa Kadıhasanoğlu 209 0.2× 229 0.2× 81 0.2× 60 0.2× 44 0.2× 53 1.1k
Y. Brault 281 0.2× 112 0.1× 228 0.5× 176 0.5× 35 0.1× 48 1.6k
William R. Kinkel 302 0.2× 155 0.1× 171 0.4× 21 0.1× 340 1.3× 40 1.8k
Michael Bynevelt 164 0.1× 183 0.2× 158 0.3× 21 0.1× 119 0.5× 58 1.5k

Countries citing papers authored by Anne E. Hammer

Since Specialization
Citations

This map shows the geographic impact of Anne E. Hammer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne E. Hammer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne E. Hammer more than expected).

Fields of papers citing papers by Anne E. Hammer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne E. Hammer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne E. Hammer. The network helps show where Anne E. Hammer may publish in the future.

Co-authorship network of co-authors of Anne E. Hammer

This figure shows the co-authorship network connecting the top 25 collaborators of Anne E. Hammer. A scholar is included among the top collaborators of Anne E. Hammer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne E. Hammer. Anne E. Hammer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
D’Cruz, David, et al.. (2023). Safety and efficacy of belimumab in older adults with SLE: results of an integrated analysis of clinical trial data. Lupus Science & Medicine. 10(1). e000830–e000830. 3 indexed citations
2.
Denton, Christopher P., Robert Spiera, David J. Jörg, et al.. (2023). AB0904 BELIMUMAB FOR THE TREATMENT OF INTERSTITIAL LUNG DISEASE ASSOCIATED WITH SYSTEMIC SCLEROSIS: A PHASE 2/3, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL. Annals of the Rheumatic Diseases. 82. 1668–1668. 1 indexed citations
3.
Suh, Chang‐Hee, Anne E. Hammer, Yeong Wook Song, et al.. (2023). Efficacy and safety of intravenous belimumab in a subgroup of South Korean patients with systemic lupus erythematosus enrolled into a Phase 3, randomized, placebo‐controlled trial in North East Asia. International Journal of Rheumatic Diseases. 27(1). e14997–e14997. 3 indexed citations
4.
Brunner, Hermine I., Carlos Abud‐Mendoza, Masaaki Mori, et al.. (2021). Efficacy and safety of belimumab in paediatric and adult patients with systemic lupus erythematosus: an across-study comparison. RMD Open. 7(3). e001747–e001747. 19 indexed citations
5.
Sheikh, Saira Z., N. L. Fox, Anne E. Hammer, et al.. (2016). AB0416 Reliability and Safety of A Novel Autoinjector for Self-Administration of Subcutaneous Belimumab in Patients with Systemic Lupus Erythematosus (SLE). Annals of the Rheumatic Diseases. 75. 1048–1049. 1 indexed citations
6.
Biton, Victor, Bassel F. Shneker, Dean K. Naritoku, et al.. (2013). Long-Term Tolerability and Safety of Lamotrigine Extended-Release: Pooled Analysis of Three Clinical Trials. Clinical Drug Investigation. 33(5). 359–364. 14 indexed citations
7.
French, Jacqueline A., Nancy Temkin, Bassel F. Shneker, et al.. (2011). Lamotrigine XR Conversion to Monotherapy: First Study Using a Historical Control Group. Neurotherapeutics. 9(1). 176–184. 44 indexed citations
8.
Fakhoury, Toufic, et al.. (2008). Effects of Lamotrigine on Mood in Older Adults with Epilepsy and Co-Morbid Depressive Symptoms. Drugs & Aging. 25(11). 955–962. 26 indexed citations
9.
Mills, Kenneth C., Joseph F. Drazkowski, Anne E. Hammer, et al.. (2007). Relative influences of adjunctive topiramate and adjunctive lamotrigine on scanning and the effective field of view. Epilepsy Research. 78(2-3). 140–146. 9 indexed citations
10.
Silver, Marianne T., David Blum, J. Grainger, Anne E. Hammer, & Steve Quessy. (2007). Double-Blind, Placebo-Controlled Trial of Lamotrigine in Combination with Other Medications for Neuropathic Pain. Journal of Pain and Symptom Management. 34(4). 446–454. 64 indexed citations
11.
12.
Fakhoury, Toufic, et al.. (2006). Lamotrigine in patients with epilepsy and comorbid depressive symptoms. Epilepsy & Behavior. 10(1). 155–162. 28 indexed citations
13.
Hammer, Anne E., et al.. (2005). Effects of lamotrigine monotherapy in patients with newly diagnosed juvenile myoclonic epilepsy: An open-label study. Current Therapeutic Research. 66(3). 230–237. 5 indexed citations
14.
Kustra, Robert P., Kimford J. Meador, Bradley K. Evans, et al.. (2005). Lamotrigine therapy in patients requiring a change in antiepileptic drug regimen. Seizure. 14(4). 254–261. 8 indexed citations
15.
Sale, Mark, Victor Biton, Alain Vuong, et al.. (2004). A dosing algorithm for converting from valproate monotherapy to lamotrigine monotherapy in patients with epilepsy. Epilepsy & Behavior. 6(1). 63–70. 6 indexed citations
16.
Cramer, Joyce A., Anne E. Hammer, & Robert P. Kustra. (2004). Quality of life improvement with conversion to lamotrigine monotherapy. Epilepsy & Behavior. 5(2). 224–230. 46 indexed citations
17.
Cramer, Joyce A., Anne E. Hammer, & Robert P. Kustra. (2004). Improved mood states with lamotrigine in patients with epilepsy. Epilepsy & Behavior. 5(5). 702–707. 38 indexed citations
18.
Fakhoury, Toufic, Anne E. Hammer, Alain Vuong, & John A. Messenheimer. (2004). Efficacy and tolerability of conversion to monotherapy with lamotrigine compared with valproate and carbamazepine in patients with epilepsy. Epilepsy & Behavior. 5(4). 532–538. 16 indexed citations
19.
McKee, Jerry, et al.. (2003). Lamotrigine as adjunctive therapy in patients with refractory epilepsy and mental retardation. Epilepsy & Behavior. 4(4). 386–394. 16 indexed citations
20.
Hammer, Anne E., et al.. (2003). Lamotrigine monotherapy compared with carbamazepine, phenytoin, or valproate monotherapy in patients with epilepsy. Epilepsy & Behavior. 4(6). 659–666. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G D Perkin Breakdown of academic impact, for papers by Ramesh K. Gupta Breakdown of academic impact, for papers by Mustafa Uzan Breakdown of academic impact, for papers by Peter R. Kinkel Breakdown of academic impact, for papers by Andrew Lux Breakdown of academic impact, for papers by Roberto Ratiglia Breakdown of academic impact, for papers by Mustafa Kadıhasanoğlu Breakdown of academic impact, for papers by Y. Brault Breakdown of academic impact, for papers by William R. Kinkel Breakdown of academic impact, for papers by Michael Bynevelt
Rankless by CCL
2026